Kshirsagar AV - Search Results

1

Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference.

Babitt JL, Eisenga MF, Haase VH, Kshirsagar AV, Levin A, Locatelli F, Małyszko J, Swinkels DW, Tarng DC, Cheung M, Jadoul M, Winkelmayer WC, Drüeke TB; Conference Participants. Babitt JL, et al. Among authors: kshirsagar av. Kidney Int. 2021 Jun;99(6):1280-1295. doi: 10.1016/j.kint.2021.03.020. Epub 2021 Apr 8. Kidney Int. 2021. PMID: 33839163 Free article.

2

Periodontal disease adversely affects the survival of patients with end-stage renal disease.

Kshirsagar AV, Craig RG, Moss KL, Beck JD, Offenbacher S, Kotanko P, Klemmer PJ, Yoshino M, Levin NW, Yip JK, Almas K, Lupovici EM, Usvyat LA, Falk RJ. Kshirsagar AV, et al. Kidney Int. 2009 Apr;75(7):746-51. doi: 10.1038/ki.2008.660. Epub 2009 Jan 21. Kidney Int. 2009. PMID: 19165177 Free article.

3

Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients.

Derebail VK, Nachman PH, Key NS, Ansede H, Falk RJ, Rosamond WD, Kshirsagar AV. Derebail VK, et al. Among authors: kshirsagar av. Kidney Int. 2011 Nov;80(9):992-999. doi: 10.1038/ki.2011.247. Epub 2011 Aug 17. Kidney Int. 2011. PMID: 21849972 Free PMC article.

4

Changing patterns of anemia management in US hemodialysis patients.

Freburger JK, Ng LJ, Bradbury BD, Kshirsagar AV, Brookhart MA. Freburger JK, et al. Among authors: kshirsagar av. Am J Med. 2012 Sep;125(9):906-14.e9. doi: 10.1016/j.amjmed.2012.03.011. Am J Med. 2012. PMID: 22938926

5

The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients.

Kshirsagar AV, Freburger JK, Ellis AR, Wang L, Winkelmayer WC, Brookhart MA. Kshirsagar AV, et al. Am J Med. 2013 Jun;126(6):541.e1-541.e14. doi: 10.1016/j.amjmed.2012.11.030. Epub 2013 Apr 15. Am J Med. 2013. PMID: 23597800 Free PMC article.

6

Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients.

Brookhart MA, Freburger JK, Ellis AR, Wang L, Winkelmayer WC, Kshirsagar AV. Brookhart MA, et al. Among authors: kshirsagar av. J Am Soc Nephrol. 2013 Jun;24(7):1151-8. doi: 10.1681/ASN.2012121164. Epub 2013 Jun 20. J Am Soc Nephrol. 2013. PMID: 23787911 Free PMC article.

7

Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients.

Kshirsagar AV, Freburger JK, Ellis AR, Wang L, Winkelmayer WC, Brookhart MA. Kshirsagar AV, et al. PLoS One. 2013 Nov 1;8(11):e78930. doi: 10.1371/journal.pone.0078930. eCollection 2013. PLoS One. 2013. PMID: 24223866 Free PMC article.

8

Bile cast nephropathy.

Jain K, Gupta A, Singh HK, Nickeleit V, Kshirsagar AV. Jain K, et al. Among authors: kshirsagar av. Kidney Int. 2015 Feb;87(2):484. doi: 10.1038/ki.2014.233. Kidney Int. 2015. PMID: 25635725 Free article. No abstract available.

9

Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients.

Brookhart MA, Freburger JK, Ellis AR, Winkelmayer WC, Wang L, Kshirsagar AV. Brookhart MA, et al. Among authors: kshirsagar av. Am J Kidney Dis. 2016 Jan;67(1):119-27. doi: 10.1053/j.ajkd.2015.07.026. Epub 2015 Sep 16. Am J Kidney Dis. 2016. PMID: 26385819

10

Trends in Anemia Management in Hemodialysis Patients with Cancer.

Butler AM, Kshirsagar AV, Olshan AF, Nielsen ME, Wheeler SB, Brookhart MA. Butler AM, et al. Among authors: kshirsagar av. Am J Nephrol. 2015;42(3):206-15. doi: 10.1159/000440771. Epub 2015 Oct 7. Am J Nephrol. 2015. PMID: 26439712 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters